Steven D. Podos

1.1k total citations
33 papers, 884 citations indexed

About

Steven D. Podos is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Steven D. Podos has authored 33 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Hematology. Recurrent topics in Steven D. Podos's work include Complement system in diseases (10 papers), Cancer therapeutics and mechanisms (9 papers) and Blood groups and transfusion (7 papers). Steven D. Podos is often cited by papers focused on Complement system in diseases (10 papers), Cancer therapeutics and mechanisms (9 papers) and Blood groups and transfusion (7 papers). Steven D. Podos collaborates with scholars based in United States, United Kingdom and Switzerland. Steven D. Podos's co-authors include Edwin L. Ferguson, Jane A. Thanassi, Michael J. Pucci, Milind Deshpande, Jason A. Wiles, Yu‐Chiun Wang, Kirsten K. Hanson, Mingjun Huang, Barton J. Bradbury and John B. Hudson and has published in prestigious journals such as The Journal of Cell Biology, Blood and Molecular and Cellular Biology.

In The Last Decade

Steven D. Podos

31 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven D. Podos United States	16	588	142	121	117	82	33	884
Zhen Tong United Kingdom	8	453 0.8×	46 0.3×	43 0.4×	80 0.7×	52 0.6×	10	714
Elsy M. Ngwa Switzerland	6	553 0.9×	180 1.3×	79 0.7×	70 0.6×	7 0.1×	7	643
Anil D’Souza United States	11	319 0.5×	203 1.4×	83 0.7×	88 0.8×	18 0.2×	18	620
Pi-Wan Cheng United States	19	666 1.1×	179 1.3×	105 0.9×	197 1.7×	6 0.1×	32	893
Zaneta Zaborowska Germany	6	556 0.9×	33 0.2×	32 0.3×	19 0.2×	14 0.2×	7	782
June Ereño‐Orbea Spain	15	494 0.8×	198 1.4×	88 0.7×	38 0.3×	7 0.1×	31	866
Takeo Tatsuta Japan	12	336 0.6×	174 1.2×	36 0.3×	40 0.3×	5 0.1×	27	460
Michelle A. Hughes United Kingdom	17	1.1k 1.9×	500 3.5×	26 0.2×	97 0.8×	7 0.1×	24	1.5k
Ashok D. Bandaranayake United States	11	428 0.7×	317 2.2×	12 0.1×	47 0.4×	26 0.3×	16	793

Countries citing papers authored by Steven D. Podos

Since Specialization

Citations

This map shows the geographic impact of Steven D. Podos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven D. Podos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven D. Podos more than expected).

Fields of papers citing papers by Steven D. Podos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven D. Podos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven D. Podos. The network helps show where Steven D. Podos may publish in the future.

Co-authorship network of co-authors of Steven D. Podos

This figure shows the co-authorship network connecting the top 25 collaborators of Steven D. Podos. A scholar is included among the top collaborators of Steven D. Podos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven D. Podos. Steven D. Podos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiles, Jason A., et al.. (2025). First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases. Pharmaceutical Research. 42(7). 1119–1131.

Podos, Steven D., Howard Trachtman, Gerald B. Appel, et al.. (2022). Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan. American Journal of Nephrology. 53(10). 675–686. 11 indexed citations

Podos, Steven D., et al.. (2022). Danicopan, an Oral Complement Factor D Inhibitor, Exhibits High and Sustained Exposure in Ocular Tissues in Preclinical Studies. Translational Vision Science & Technology. 11(10). 37–37. 15 indexed citations

Boyer, David S., José Rivera, Steven D. Podos, et al.. (2021). Oral Administration of the Complement Factor D Inhibitor Danicopan (ALXN2040) in Preclinical Studies Demonstrates High and Sustained Drug Concentrations in Posterior Ocular Tissues for the Potential Treatment of Geographic Atrophy. Investigative Ophthalmology & Visual Science. 62(8). 187–187. 6 indexed citations

Phadke, Avinash, Viral Kansara, David S. Boyer, et al.. (2020). Ocular Pharmacokinetics and Safety of Suprachoroidal A01017, Small Molecule Complement Inhibitor, Injectable Suspension in Rabbits. Investigative Ophthalmology & Visual Science. 61(7). 3694–3694. 8 indexed citations

Marlor, Christopher W., Steven D. Podos, Craig B Struble, et al.. (2020). Ocular Tissue Distribution of the Complement Factor D Inhibitor Danicopan Following Oral Administration in Rabbits. Investigative Ophthalmology & Visual Science. 61(7). 4916–4916. 1 indexed citations

Wiles, Jason A., Manuel Galvan, Steven D. Podos, Michael Geffner, & Mingjun Huang. (2019). Discovery and Development of the Oral Complement Factor D Inhibitor Danicopan (ACH-4471). Current Medicinal Chemistry. 27(25). 4165–4180. 33 indexed citations

Yuan, Xuan, Eleni Gavriilaki, Jane A. Thanassi, et al.. (2016). Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Haematologica. 102(3). 466–475. 82 indexed citations

Thanassi, Jane A., Guangwei Yang, Manuel Galvan, et al.. (2016). Comparison of complement functional assays: Differential sensitivities of hemolysis and Wieslab assays to levels of complement proteins C5, factor B, and factor D. Immunobiology. 221(10). 1169–1169. 1 indexed citations

10.

Yuan, Xuan, Guangwei Yang, Jane A. Thanassi, et al.. (2016). Evaluation of Bacteria-Mediated Potential "Bystander" Hemolysis of PNH RED CELLS In Vitro: NO Evidence of Significant Complement Classical or Lectin Pathway-Mediated Hemolysis Induced by Microorganisms. Blood. 128(22). 2431–2431. 2 indexed citations

11.

Yang, Guo‐Min, Yanan Zhao, J. Fabrycki, et al.. (2013). 1199 FINDINGS FROM CLINICAL VIROLOGY STUDIES ON ACH-3102 ARE CONSISTENT WITH PRECLINICAL OBSERVATIONS ON ITS IMPROVED POTENCY AGAINST GENOTYPE-1a HCV AND RESISTANT VARIANTS. Journal of Hepatology. 58. S487–S488. 1 indexed citations

12.

Moraski, Garrett C., Jane A. Thanassi, Steven D. Podos, Michael J. Pucci, & Marvin J. Miller. (2011). One-step syntheses of nitrofuranyl benzimidazoles that are active against multidrug-resistant bacteria. The Journal of Antibiotics. 64(10). 667–671. 11 indexed citations

13.

Kim, Ha-Young, Jason A. Wiles, Qiuping Wang, et al.. (2011). Exploration of the Activity of 7-Pyrrolidino-8-methoxyisothiazoloquinolones against Methicillin-Resistant Staphylococcus aureus (MRSA). Journal of Medicinal Chemistry. 54(9). 3268–3282. 29 indexed citations

14.

Agarwal, Atul, Shirley Louise‐May, Jane A. Thanassi, et al.. (2007). Small molecule inhibitors of E. coli primase, a novel bacterial target. Bioorganic & Medicinal Chemistry Letters. 17(10). 2807–2810. 38 indexed citations

15.

Wang, Qiuping, Akihiro Hashimoto, Godwin C. G. Pais, et al.. (2006). Isothiazoloquinolones with Enhanced Antistaphylococcal Activities against Multidrug-Resistant Strains: Effects of Structural Modifications at the 6-, 7-, and 8-Positions. Journal of Medicinal Chemistry. 50(2). 199–210. 40 indexed citations

16.

Wiles, Jason A., Yongsheng Song, Qiuping Wang, et al.. (2005). Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus. Bioorganic & Medicinal Chemistry Letters. 16(5). 1277–1281. 22 indexed citations

17.

Wiles, Jason A., Qiuping Wang, Akihiro Hashimoto, et al.. (2005). Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: Synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells. Bioorganic & Medicinal Chemistry Letters. 16(5). 1272–1276. 41 indexed citations

18.

Podos, Steven D., Kirsten K. Hanson, Yu‐Chiun Wang, & Edwin L. Ferguson. (2001). The DSmurf Ubiquitin-Protein Ligase Restricts BMP Signaling Spatially and Temporally during Drosophila Embryogenesis. Developmental Cell. 1(4). 567–578. 93 indexed citations

19.

Podos, Steven D. & Edwin L. Ferguson. (1999). Morphogen gradients: new insights from DPP. Trends in Genetics. 15(10). 396–402. 101 indexed citations

20.

Podos, Steven D., et al.. (1994). LDLC encodes a brefeldin A-sensitive, peripheral Golgi protein required for normal Golgi function.. The Journal of Cell Biology. 127(3). 679–691. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact